Continuous Glucose Monitoring System Offers Advanced Diabetes Management

By HospiMedica International staff writers
Posted on 29 Jun 2010
An innovative continuous glucose monitoring (CGM) system detects high and low glucose fluctuations that can lead to dangerous health complications, which often go undetected with traditional A1C and glucose meter readings.

The Medtronic iPro2 Professional CGM system uses a tiny, disposable glucose sensor to record as many as 288 readings over a 24-hour period. The system includes the glucose sensor and a small data recorder that automatically records the glucose information. The patients wear the lightweight, watertight device while going about their normal daily activities, before returning it to their physicians' office for evaluation. Once returned, the glucose information stored on the device is uploaded (using a proprietary docking station) to the CareLink iPro software, a fully integrated, web-based platform that stores the data from iPro2 Professional CGM and simplifies data evaluation.

Image: The Medtronic iPro2 Professional CGM and Docking Station (photo courtesy Medtronic).

Attending physicians can then remotely access the software, using any computer with an internet connection. Reports containing continuous glucose information are well organized and capture important glucose trends, such as hyperglycemic and hypoglycemic episodes, that could affect treatment decisions. The reports are also useful for educating and motivating patients to implement changes in their diabetes management, after viewing the effects that specific foods, exercise, stress, and medications have on their glucose levels. The Medtronic iPro2 Professional CGM is a product of Medtronic (Minneapolis, MN, USA), and has received the Conformité Européenne (CE) Marking of approval.

"It's never been easier to reveal previously undetected high and low glucose excursions and understand their causes. This information is helpful for making better treatment decisions to improve patients' lives,” said Francine Kaufman, M.D., chief medical officer and vice president of global medical, clinical, and health affairs of the Medtronic diabetes business. "Moreover, iPro2 Professional CGM is quick to implement and provides reports that physicians can use to educate patients on the therapy and lifestyle changes they can make to improve their health and quality of life.”

Related Links:

Medtronic



Latest Critical Care News